Genocea Provides Fourth Quarter 2021 Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Genocea Biosciences (GNCA) Tops Q4 EPS by 1c
March 10, 2022 7:01 AM ESTGenocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20).
Genoceas existing cash is sufficient to support our current operations into Q3 2022, however we have strategic plans to extend our operations into 2023.
For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.
... More